#VisualAbstract: Semaglutide Improves Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
studygraphics
#VisualAbstract: Dupilumab Improves Outcomes in COPD with Blood Eosinophil Evidence of Type 2 Inflammation
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Ticagrelor monotherapy reduces bleeding risk following percutaneous coronary intervention
1. Clinically relevant bleeding was significantly lower with ticagrelor monotherapy than in the...
Read More
#VisualAbstract: Nirmatrelvir does not decrease symptom duration of COVID-19
1. In this randomized controlled trial, there was no difference in the median time to sustained...
Read More
#VisualAbstract: Intensive Ambulance-Delivered Blood-Pressure Reduction Does Not Improve Outcomes in Hyperacute Stroke
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Single-Agent Trabectedin was noninferior to physicianAND#8217;s choice control chemotherapy in recurrent ovarian cancer
Click here to read this study in the Journal of Clinical Oncology ©2024 2 Minute Medicine, Inc....
Read More
#VisualAbstract: Ponatinib is Superior to Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy
Click here to read this study in The New England Journal of Medicine. ©2024 2 Minute Medicine,...
Read More
#VisualAbstract: Intra-Articular Platelet-Rich Plasma Injection After Anterior Cruciate Ligament Reconstruction has No Impact on Recovery
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Dequalinium chloride, a broad spectrum antiseptic, is non-inferior to metronidazole for bacterial vaginosis
Click here to read the study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: The Use of Aspirin as an Adjuvant Therapy has No Impact on Breast Cancer
Click here to read the study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Semaglutide Improves Outcomes in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
Click here to to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Pembrolizumab enhances progression-free survival in patients with locally advanced cervical cancer
1. Progression-free survival at 24 months was higher in the pembrolizumab versus...
Read More
#VisualAbstract: Recombinant ADAMTS13 Prophylaxis Leads to Rare Thrombotic Thrombocytopenic Purpura Events in Patients with Congenital Thrombotic Thrombocytopenic Purpura
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
#VisualAbstract: Apolipoprotein A1 Infusions do not Improve Cardiovascular Outcomes after Acute Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read More
#VisualAbstract: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
Click to read the study in NEJM ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be...
Read More
#VisualAbstract: Overall Survival Improved with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
1. The overall survival at 48 months was 91.2% in the pembrolizumab group vs 86.0% in the placebo...
Read More
#VisualAbstract: Teplizumab Improves β-cell Function in Newly Diagnosed Type 1 Diabetes
1. In this randomized-controlled trial, two 12-day courses of teplizumab improved C-peptide levels...
Read More
#VisualAbstract: Microaxial Flow Pumps Reduces Mortality But Increases Adverse Events Compared to Standard Care For Cardiogenic Shock
Click to read the study in The New England Journal of Medicine ©2024 2 Minute Medicine, Inc. All...
Read More
#VisualAbstract: Empagliflozin does not significantly reduce the risk of heart failure or death in patients after acute myocardial infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More